(Q54346270)

28 May 2018

title

High-mobility group box 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma. (English)

1 reference

28 May 2018

author name string

Wei Jiang

1

1 reference

28 May 2018

Zhiming Wang

2

1 reference

28 May 2018

Xinying Li

3

1 reference

28 May 2018

Xuegong Fan

4

1 reference

28 May 2018

Yankun Duan

5

1 reference

28 May 2018

publication date

7 September 2011

1 reference

28 May 2018

Pathology Oncology Research

published in

1 reference

28 May 2018

volume

18

1 reference

28 May 2018

issue

2

1 reference

28 May 2018

page(s)

293-298

1 reference

28 May 2018

https://scigraph.springernature.com/pub.10.1007/s12253-011-9442-3

exact match

0 references

cites work

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9442-3

Nonhistone Proteins HMG 1 and HMG 2 Change the DNA Helical Structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9442-3

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9442-3

Dual roles for HMGB1: DNA binding and cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9442-3

New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9442-3

The expression of HMGB1 protein and its receptor RAGE in human malignant tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9442-3

Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9442-3

Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9442-3

Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9442-3

High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9442-3

Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9442-3

HMG1 and 2, and related 'architectural' DNA-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9442-3

S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9442-3

Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9442-3

The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9442-3

Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9442-3

Epidemiology of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-011-9442-3

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

21 January 2018

1 reference

12 December 2020

Expression of high mobility group box chromosomal protein-1 (HMGB-1) in gastric cancer

1 reference

12 December 2020

Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma

1 reference

12 December 2020

Specific molecular markers in hepatocellular carcinoma

1 reference

12 December 2020

HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma

1 reference

12 December 2020

Epidemiology of liver cancer: an overview.

1 reference

12 December 2020

Dual roles for HMGB1: DNA binding and cytokine

1 reference

12 December 2020

10.1007/S12253-011-9442-3

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018